Erika J Wolf1, Naomi Sadeh2, Elizabeth C Leritz3, Mark W Logue4, Tawni B Stoop5, Regina McGlinchey6, William Milberg6, Mark W Miller7. 1. National Center for PTSD, Boston, Massachusetts; Department of Psychiatry, Boston, Massachusetts. Electronic address: erika.wolf@va.gov. 2. National Center for PTSD, Boston, Massachusetts; Department of Psychiatry, Boston, Massachusetts. 3. Behavioral Science Division, Neuroimaging Research for Veterans Center, Boston, Massachusetts; Geriatric Research, Education and Clinical Center, Boston, Massachusetts; Translational Research Center for TBI and Stress Disorders, Boston, Massachusetts; Biomedical Genetics, Boston University School of Medicine, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 4. Research Service, VA Boston Healthcare System, Boston, Massachusetts; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts. 5. Boston VA Research Institute, Inc, Boston, Massachusetts. 6. Geriatric Research, Education and Clinical Center, Boston, Massachusetts; Translational Research Center for TBI and Stress Disorders, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 7. National Center for PTSD, Boston, Massachusetts; Department of Psychiatry, Boston, Massachusetts; Biomedical Genetics, Boston University School of Medicine, Boston, Massachusetts.
Abstract
BACKGROUND: Metabolic syndrome (MetS), defined by a constellation of cardiometabolic pathologies, is highly prevalent among veterans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major risk for adverse health outcomes, including neurodegeneration and mortality. Given this, we evaluated 1) the association between MetS and neural integrity, indexed by cortical thickness; 2) the relationship between PTSD and MetS; and 3) whether PTSD was associated with cortical thickness indirectly through MetS. METHODS: The sample consisted of 346 U.S. military veterans (89.3% male; 71.4% white) who deployed to Iraq, Afghanistan, or both. Neuroimaging data were available for 274 participants. RESULTS: In whole-brain analyses, MetS was negatively associated with cortical thickness in two left and four right hemisphere regions, as follows: bilateral temporal lobe, including temporal pole, fusiform gyrus, and insula, and extending into occipital cortex (left hemisphere) and orbitofrontal cortex (right hemisphere); bilateral precuneus, posterior cingulate, calcarine, and occipital-parietal cortex; and right rostral anterior cingulate cortex and central sulcus/postcentral gyrus. Path models showed that PTSD predicted MetS (β = .19, p < .001), which was associated with reduced cortical thickness (β = -.29 to -.43, all p < .001). CONCLUSIONS: Results from this young veteran sample provide evidence that PTSD confers risk for cardiometabolic pathology and neurodegeneration and raise concern that this cohort may be aging prematurely and at risk for substantial medical and cognitive decline. This study highlights the need to identify the molecular mechanisms linking PTSD to MetS and effective interventions to reduce PTSD-related health comorbidities. Published by Elsevier Inc.
BACKGROUND:Metabolic syndrome (MetS), defined by a constellation of cardiometabolic pathologies, is highly prevalent among veterans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major risk for adverse health outcomes, including neurodegeneration and mortality. Given this, we evaluated 1) the association between MetS and neural integrity, indexed by cortical thickness; 2) the relationship between PTSD and MetS; and 3) whether PTSD was associated with cortical thickness indirectly through MetS. METHODS: The sample consisted of 346 U.S. military veterans (89.3% male; 71.4% white) who deployed to Iraq, Afghanistan, or both. Neuroimaging data were available for 274 participants. RESULTS: In whole-brain analyses, MetS was negatively associated with cortical thickness in two left and four right hemisphere regions, as follows: bilateral temporal lobe, including temporal pole, fusiform gyrus, and insula, and extending into occipital cortex (left hemisphere) and orbitofrontal cortex (right hemisphere); bilateral precuneus, posterior cingulate, calcarine, and occipital-parietal cortex; and right rostral anterior cingulate cortex and central sulcus/postcentral gyrus. Path models showed that PTSD predicted MetS (β = .19, p < .001), which was associated with reduced cortical thickness (β = -.29 to -.43, all p < .001). CONCLUSIONS: Results from this young veteran sample provide evidence that PTSD confers risk for cardiometabolic pathology and neurodegeneration and raise concern that this cohort may be aging prematurely and at risk for substantial medical and cognitive decline. This study highlights the need to identify the molecular mechanisms linking PTSD to MetS and effective interventions to reduce PTSD-related health comorbidities. Published by Elsevier Inc.
Authors: Karl-Heinz Ladwig; Anne Catharina Brockhaus; Jens Baumert; Karoline Lukaschek; Rebecca T Emeny; Johannes Kruse; Veryan Codd; Sibylle Häfner; Eva Albrecht; Thomas Illig; Nilesh J Samani; H Erich Wichmann; Christian Gieger; Annette Peters Journal: PLoS One Date: 2013-07-03 Impact factor: 3.240
Authors: Ekaterina Tchistiakova; Nicole D Anderson; Carol E Greenwood; Bradley J MacIntosh Journal: Neuroimage Clin Date: 2014-06-05 Impact factor: 4.881
Authors: E J Wolf; M J Bovin; J D Green; K S Mitchell; T B Stoop; K M Barretto; C E Jackson; L O Lee; S C Fang; F Trachtenberg; R C Rosen; T M Keane; B P Marx Journal: Psychol Med Date: 2016-04-18 Impact factor: 7.723
Authors: Jeffrey M Spielberg; Naomi Sadeh; Elizabeth C Leritz; Regina E McGlinchey; William P Milberg; Jasmeet P Hayes; David H Salat Journal: Hum Brain Mapp Date: 2017-03-31 Impact factor: 5.038
Authors: Serguei V Astafiev; Jie Wen; David L Brody; Anne H Cross; Andrey P Anokhin; Kristina L Zinn; Maurizio Corbetta; Dmitriy A Yablonskiy Journal: Mil Med Date: 2019-03-01 Impact factor: 1.437
Authors: Erika J Wolf; Filomene G Morrison; Danielle R Sullivan; Mark W Logue; Rachel E Guetta; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Mark W Miller Journal: Brain Behav Immun Date: 2019-03-11 Impact factor: 7.217
Authors: M W Miller; H Maniates; E J Wolf; M W Logue; S A Schichman; A Stone; W Milberg; R McGlinchey Journal: Brain Behav Immun Date: 2017-09-01 Impact factor: 7.217